"Parkinson Disease" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75)
Descriptor ID |
D010300
|
MeSH Number(s) |
C10.228.140.079.862.500 C10.228.662.600.400 C10.574.812
|
Concept/Terms |
Parkinson Disease- Parkinson Disease
- Idiopathic Parkinson's Disease
- Lewy Body Parkinson Disease
- Lewy Body Parkinson's Disease
- Primary Parkinsonism
- Parkinsonism, Primary
- Parkinson Disease, Idiopathic
- Parkinson's Disease
- Parkinson's Disease, Idiopathic
- Parkinson's Disease, Lewy Body
- Idiopathic Parkinson Disease
- Paralysis Agitans
|
Below are MeSH descriptors whose meaning is more general than "Parkinson Disease".
Below are MeSH descriptors whose meaning is more specific than "Parkinson Disease".
This graph shows the total number of publications written about "Parkinson Disease" by people in this website by year, and whether "Parkinson Disease" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 0 | 1 | 1 |
1995 | 4 | 0 | 4 |
1996 | 2 | 0 | 2 |
1997 | 6 | 2 | 8 |
1998 | 6 | 2 | 8 |
1999 | 15 | 2 | 17 |
2000 | 10 | 2 | 12 |
2001 | 13 | 0 | 13 |
2002 | 10 | 1 | 11 |
2003 | 13 | 3 | 16 |
2004 | 14 | 3 | 17 |
2005 | 19 | 4 | 23 |
2006 | 19 | 2 | 21 |
2007 | 22 | 1 | 23 |
2008 | 21 | 5 | 26 |
2009 | 22 | 5 | 27 |
2010 | 28 | 2 | 30 |
2011 | 26 | 2 | 28 |
2012 | 23 | 2 | 25 |
2013 | 23 | 1 | 24 |
2014 | 26 | 2 | 28 |
2015 | 22 | 4 | 26 |
2016 | 14 | 4 | 18 |
2017 | 18 | 2 | 20 |
2018 | 21 | 1 | 22 |
2019 | 18 | 1 | 19 |
2020 | 20 | 1 | 21 |
2021 | 24 | 2 | 26 |
2022 | 15 | 0 | 15 |
2023 | 22 | 0 | 22 |
2024 | 3 | 0 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Parkinson Disease" by people in Profiles.
-
Herpes Zoster and Risk of Incident Parkinson's Disease in US Veterans: A Matched Cohort Study. Mov Disord. 2024 Feb; 39(2):438-444.
-
Safety, tolerability, and efficacy of NLY01 in early untreated Parkinson's disease: a randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2024 Jan; 23(1):37-45.
-
Delivering Multidisciplinary Rehabilitation Care in Parkinson's Disease: An International Consensus Statement. J Parkinsons Dis. 2024; 14(1):135-166.
-
Botulinum toxin treatment in parkinsonism. J Neurol Sci. 2024 Jan 15; 456:122810.
-
Establishing an online resource to facilitate global collaboration and inclusion of underrepresented populations: Experience from the MJFF Global Genetic Parkinson's Disease Project. PLoS One. 2023; 18(10):e0292180.
-
Linking the cerebellum to Parkinson disease: an update. Nat Rev Neurol. 2023 11; 19(11):645-654.
-
Utilizing speech analysis to differentiate progressive supranuclear palsy from Parkinson's disease. Parkinsonism Relat Disord. 2023 Oct; 115:105835.
-
Multiancestry analysis of the HLA locus in Alzheimer's and Parkinson's diseases uncovers a shared adaptive immune response mediated by HLA-DRB1*04 subtypes. Proc Natl Acad Sci U S A. 2023 09 05; 120(36):e2302720120.
-
Retinal Thickness in Essential Tremor and Early Parkinson Disease: Exploring Diagnostic Insights. J Neuroophthalmol. 2024 Mar 01; 44(1):35-40.
-
Spinal cord stimulation for gait disturbances in Parkinson's disease. Expert Rev Neurother. 2023 Jul-Dec; 23(7):651-659.